TWIST interacts with β-catenin signaling on osteosarcoma cell survival against cisplatin

Jianhuang Wu1, Qiande Liao, Hongbo He

  • 1Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Spine, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Molecular Carcinogenesis
|January 3, 2013
PubMed

Insights

TWIST reduces osteosarcoma cell survival against cisplatin by decreasing soluble β-catenin levels via PI3K signaling. This reveals a novel functional link between TWIST and β-catenin in osteosarcoma development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • TWIST and Wnt/β-catenin signaling are implicated in osteosarcoma.
  • Understanding their interaction is crucial for therapeutic strategies.

Purpose of the Study:

  • To investigate TWIST's regulation of β-catenin in osteosarcoma cells.
  • To determine the impact of TWIST-β-catenin interaction on cisplatin resistance.

Main Methods:

  • TWIST overexpression in Saos-2 cells and knockdown in MG-63 cells.
  • Assessed soluble β-catenin levels, GSK-3β phosphorylation, and target gene expression.
  • Evaluated cell survival against cisplatin, with and without β-catenin or PI3K inhibition.

Main Results:

  • TWIST overexpression decreased soluble β-catenin, GSK-3β phosphorylation, target gene expression, and cisplatin resistance.
  • TWIST knockdown increased soluble β-catenin, GSK-3β phosphorylation, target gene expression, and cisplatin resistance.
  • TWIST's effects were mediated by PI3K signaling and linked to β-catenin levels.

Conclusions:

  • TWIST diminishes osteosarcoma cell survival against cisplatin by reducing soluble β-catenin through a PI3K-dependent pathway.
  • This study establishes a functional link between TWIST and β-catenin signaling in osteosarcoma.
  • Provides new insights into osteosarcoma molecular mechanisms and potential therapeutic targets.

Related Concept Videos

Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...